Trade Natera, Inc. - NTRA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | - | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.024068% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.001846% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | N/A |
Open* | N/A |
1-Year Change* | N/A |
Day's Range* | N/A |
52 wk Range | 27.35-59.75 |
Average Volume (10 days) | 1.44M |
Average Volume (3 months) | 28.47M |
Market Cap | 6.31B |
P/E Ratio | -100.00K |
Shares Outstanding | 113.29M |
Revenue | 820.22M |
EPS | -5.57 |
Dividend (Yield %) | N/A |
Beta | 1.19 |
Next Earnings Date | May 3, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|
Natera, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total revenue | 625.486 | 391.005 | 302.328 | 257.654 | 209.625 |
Revenue | 625.486 | 391.005 | 302.328 | 257.654 | 209.625 |
Cost of Revenue, Total | 318.418 | 203.62 | 175.47 | 166.055 | 139.596 |
Gross Profit | 307.068 | 187.385 | 126.858 | 91.599 | 70.029 |
Total Operating Expense | 1093.66 | 613.13 | 418.615 | 372.282 | 344.966 |
Selling/General/Admin. Expenses, Total | 511.034 | 303.627 | 204.476 | 154.872 | 155.306 |
Research & Development | 264.208 | 100.035 | 51.357 | 51.355 | 50.064 |
Operating Income | -468.174 | -222.125 | -116.287 | -114.628 | -135.341 |
Interest Income (Expense), Net Non-Operating | -8.305 | -15.082 | -10.693 | -10.476 | -4.213 |
Other, Net | 5.381 | 7.562 | 4.152 | -2.729 | 2.38 |
Net Income Before Taxes | -471.098 | -229.645 | -122.828 | -127.833 | -137.174 |
Net Income After Taxes | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
Net Income Before Extra. Items | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
Net Income | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
Income Available to Common Excl. Extra. Items | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
Income Available to Common Incl. Extra. Items | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
Diluted Net Income | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
Diluted Weighted Average Shares | 90.558 | 81.011 | 69.555 | 57.848 | 53.312 |
Diluted EPS Excluding Extraordinary Items | -5.20899 | -2.83595 | -1.79465 | -2.21536 | -2.58156 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Diluted Normalized EPS | -5.20899 | -2.78903 | -1.91322 | -2.21536 | -2.58156 |
Total Extraordinary Items | 0 | ||||
Unusual Expense (Income) | 0 | 5.848 | -12.688 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total revenue | 194.133 | 173.028 | 158.116 | 142.026 | 152.316 |
Revenue | 194.133 | 173.028 | 158.116 | 142.026 | 152.316 |
Cost of Revenue, Total | 103.215 | 94.122 | 81.371 | 76.112 | 66.813 |
Gross Profit | 90.918 | 78.906 | 76.745 | 65.914 | 85.503 |
Total Operating Expense | 331.263 | 312.694 | 308.313 | 257.32 | 215.333 |
Selling/General/Admin. Expenses, Total | 147.634 | 146.761 | 128.485 | 127.456 | 108.332 |
Research & Development | 80.414 | 71.811 | 98.457 | 53.752 | 40.188 |
Operating Income | -137.13 | -139.666 | -150.197 | -115.294 | -63.017 |
Interest Income (Expense), Net Non-Operating | -2.087 | -2.079 | -2.078 | -2.075 | -2.073 |
Other, Net | 0.801 | 1.151 | 1.274 | 1.585 | 1.371 |
Net Income Before Taxes | -138.416 | -140.594 | -151.001 | -115.784 | -63.719 |
Net Income After Taxes | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
Net Income Before Extra. Items | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
Net Income | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
Income Available to Common Excl. Extra. Items | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
Income Available to Common Incl. Extra. Items | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
Diluted Net Income | -138.595 | -140.564 | -151.273 | -116.026 | -63.853 |
Diluted Weighted Average Shares | 95.578 | 94.842 | 92.558 | 88.077 | 86.689 |
Diluted EPS Excluding Extraordinary Items | -1.45007 | -1.48209 | -1.63436 | -1.31732 | -0.73658 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -1.45007 | -1.48209 | -1.63436 | -1.31732 | -0.73658 |
Unusual Expense (Income) | 0 | 0 | 0 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 1093.14 | 862.663 | 523.167 | 240.518 | 180.625 |
Cash and Short Term Investments | 914.282 | 737.274 | 440.991 | 153.868 | 118.867 |
Cash & Equivalents | 84.386 | 48.668 | 61.926 | 46.407 | 12.62 |
Short Term Investments | 829.896 | 688.606 | 379.065 | 107.461 | 106.247 |
Total Receivables, Net | 122.074 | 78.565 | 53.351 | 62.223 | 44.089 |
Accounts Receivable - Trade, Net | 122.074 | 78.565 | 53.351 | 62.223 | 44.089 |
Total Inventory | 26.909 | 20.031 | 12.394 | 13.633 | 8.998 |
Prepaid Expenses | 29.645 | 26.606 | 16.376 | 6.197 | 8.612 |
Other Current Assets, Total | 0.228 | 0.187 | 0.055 | 4.597 | 0.059 |
Total Assets | 1236.49 | 932.153 | 582.656 | 268.171 | 214.613 |
Property/Plant/Equipment, Total - Net | 124.529 | 54.747 | 47.013 | 24.336 | 29.667 |
Property/Plant/Equipment, Total - Gross | 143.942 | 104.801 | 88.537 | 58.633 | 56.652 |
Accumulated Depreciation, Total | -19.413 | -50.054 | -41.524 | -34.297 | -26.985 |
Other Long Term Assets, Total | 18.82 | 14.743 | 12.476 | 3.317 | 4.321 |
Total Current Liabilities | 218.956 | 199.053 | 179.874 | 113.981 | 105.561 |
Accounts Payable | 27.206 | 8.096 | 8.604 | 14.587 | 8.529 |
Accrued Expenses | 114.854 | 71.689 | 54.03 | 33.843 | 35.558 |
Notes Payable/Short Term Debt | 50.052 | 50.054 | 50.123 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 50.153 | 50.112 | |||
Other Current Liabilities, Total | 26.844 | 69.214 | 67.117 | 15.398 | 11.362 |
Total Liabilities | 583.183 | 445.917 | 303.945 | 236.009 | 189.196 |
Total Long Term Debt | 280.394 | 202.493 | 73.656 | 73.357 | 73.065 |
Other Liabilities, Total | 83.833 | 44.371 | 50.415 | 48.671 | 10.57 |
Total Equity | 653.304 | 486.236 | 278.711 | 32.162 | 25.417 |
Preferred Stock - Non Redeemable, Net | 0 | ||||
Common Stock | 0.01 | 0.009 | 0.008 | 0.007 | 0.006 |
Additional Paid-In Capital | 2050.42 | 1411.29 | 976.955 | 607.236 | 472.552 |
Retained Earnings (Accumulated Deficit) | -1394.84 | -929.318 | -699.171 | -574.529 | -446.375 |
Other Equity, Total | -2.287 | 4.259 | 0.919 | -0.552 | -0.766 |
Total Liabilities & Shareholders’ Equity | 1236.49 | 932.153 | 582.656 | 268.171 | 214.613 |
Total Common Shares Outstanding | 95.14 | 86.223 | 78.005 | 62.083 | 54.04 |
Long Term Debt | 280.394 | 202.493 | 73.656 | 73.357 | 73.065 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 980.226 | 1093.14 | 1191.22 | 739.888 | 791.403 |
Cash and Short Term Investments | 751.958 | 914.282 | 1023.7 | 580.243 | 653.572 |
Cash & Equivalents | 158.298 | 84.386 | 95.103 | 62.811 | 65.126 |
Short Term Investments | 593.66 | 829.896 | 928.596 | 517.432 | 588.446 |
Total Receivables, Net | 167.862 | 122.074 | 110.416 | 100.13 | 87.562 |
Accounts Receivable - Trade, Net | 167.862 | 122.074 | 110.416 | 100.13 | 87.562 |
Total Inventory | 25.048 | 26.909 | 28.022 | 28.409 | 23.676 |
Prepaid Expenses | 35.13 | 29.645 | 28.858 | 30.878 | 26.43 |
Other Current Assets, Total | 0.228 | 0.228 | 0.228 | 0.228 | 0.163 |
Total Assets | 1144.66 | 1236.49 | 1311.37 | 849.956 | 893.512 |
Property/Plant/Equipment, Total - Net | 142.762 | 124.529 | 106.949 | 97.221 | 89.703 |
Property/Plant/Equipment, Total - Gross | 165.177 | 143.942 | 165.263 | 152.538 | 142.306 |
Accumulated Depreciation, Total | -22.415 | -19.413 | -58.314 | -55.317 | -52.603 |
Other Long Term Assets, Total | 21.676 | 18.82 | 13.202 | 12.847 | 12.406 |
Total Current Liabilities | 231.072 | 218.956 | 199.714 | 197.988 | 166.969 |
Accounts Payable | 18.07 | 27.206 | 8.181 | 20.307 | 4.682 |
Accrued Expenses | 130.919 | 114.854 | 114.18 | 93.183 | 81.711 |
Notes Payable/Short Term Debt | 50.055 | 50.052 | 50.049 | 50.049 | 50.052 |
Other Current Liabilities, Total | 32.028 | 26.844 | 27.304 | 34.449 | 30.524 |
Total Liabilities | 602.329 | 583.183 | 552.357 | 550.846 | 521.067 |
Total Long Term Debt | 280.706 | 280.394 | 280.085 | 279.777 | 279.471 |
Long Term Debt | 280.706 | 280.394 | 280.085 | 279.777 | 279.471 |
Other Liabilities, Total | 90.551 | 83.833 | 72.558 | 73.081 | 74.627 |
Total Equity | 542.335 | 653.304 | 759.017 | 299.11 | 372.445 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.009 | 0.009 |
Additional Paid-In Capital | 2089.66 | 2050.42 | 2011.79 | 1399.66 | 1356.21 |
Retained Earnings (Accumulated Deficit) | -1533.43 | -1394.84 | -1254.27 | -1103 | -986.973 |
Other Equity, Total | -13.904 | -2.287 | 1.491 | 2.441 | 3.197 |
Total Liabilities & Shareholders’ Equity | 1144.66 | 1236.49 | 1311.37 | 849.956 | 893.512 |
Total Common Shares Outstanding | 96.259 | 95.14 | 94.538 | 88.498 | 87.43 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
Cash From Operating Activities | -335.236 | -182.512 | -63.444 | -70.581 | -97.825 |
Cash From Operating Activities | 11.254 | 8.613 | 7.73 | 7.501 | 7.143 |
Non-Cash Items | 171.299 | 77.748 | 26.452 | 22.916 | 13.05 |
Cash Taxes Paid | 0.283 | 0.067 | 2.154 | 0.332 | 0.177 |
Cash Interest Paid | 7.077 | 3.296 | 12.455 | 7.914 | 3.568 |
Changes in Working Capital | -46.073 | -39.13 | 27.201 | 27.156 | 19.61 |
Cash From Investing Activities | -205.193 | -331.461 | -266.353 | -5.161 | 13.784 |
Capital Expenditures | -49.588 | -19.604 | -4.968 | -3.88 | -9.867 |
Other Investing Cash Flow Items, Total | -155.605 | -311.857 | -261.385 | -1.281 | 23.651 |
Cash From Financing Activities | 576.188 | 500.847 | 340.774 | 113.725 | 80.372 |
Issuance (Retirement) of Stock, Net | 576.188 | 301.288 | 340.774 | 113.725 | 5.659 |
Issuance (Retirement) of Debt, Net | 0 | 199.559 | 0 | 0 | 75 |
Net Change in Cash | 35.759 | -13.126 | 10.977 | 37.983 | -3.669 |
Financing Cash Flow Items | 0 | -0.287 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -138.595 | -471.716 | -331.152 | -179.879 | -63.853 |
Cash From Operating Activities | -137.277 | -335.236 | -236.5 | -145.439 | -74.876 |
Cash From Operating Activities | 3.002 | 11.254 | 8.259 | 5.262 | 2.549 |
Non-Cash Items | 40.865 | 171.299 | 136.312 | 68.849 | 28.676 |
Cash Interest Paid | 0.159 | 7.077 | 3.69 | 3.538 | 0.152 |
Changes in Working Capital | -42.549 | -46.073 | -49.919 | -39.671 | -42.248 |
Cash From Investing Activities | 207.033 | -205.193 | -284.697 | 146.709 | 86.74 |
Capital Expenditures | -15.885 | -49.588 | -36.298 | -18.891 | -10.26 |
Other Investing Cash Flow Items, Total | 222.918 | -155.605 | -248.399 | 165.6 | 97 |
Cash From Financing Activities | 4.156 | 576.188 | 567.673 | 12.914 | 4.57 |
Issuance (Retirement) of Stock, Net | 4.156 | 576.188 | 567.673 | 12.914 | 4.57 |
Net Change in Cash | 73.912 | 35.759 | 46.476 | 14.184 | 16.434 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7594 | 9923131 | 1628200 | 2022-12-31 | LOW |
Fred Alger Management, LLC | Investment Advisor/Hedge Fund | 7.9205 | 8972823 | 191477 | 2022-12-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.2045 | 4763130 | 715214 | 2022-12-31 | LOW |
Samlyn Capital, LLC | Hedge Fund | 3.8755 | 4390372 | 2113236 | 2022-12-31 | HIGH |
JP Morgan Asset Management | Investment Advisor | 3.739 | 4235761 | 101390 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.1533 | 3572262 | 764812 | 2022-12-31 | LOW |
Sofinnova Investments, Inc | Venture Capital | 2.7369 | 3100560 | -2400 | 2022-12-31 | MED |
Citadel Advisors LLC | Hedge Fund | 2.6914 | 3048948 | 884865 | 2022-12-31 | HIGH |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.4544 | 2780428 | 1886903 | 2022-12-31 | LOW |
Eversept Partners, LP | Hedge Fund | 2.371 | 2685959 | 1260357 | 2022-12-31 | MED |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 2.3033 | 2609283 | 400000 | 2022-12-31 | LOW |
Kynam Capital Management LP | Hedge Fund | 2.2979 | 2603207 | 584847 | 2022-12-31 | HIGH |
Principal Global Investors (Equity) | Investment Advisor | 1.7724 | 2007860 | 867205 | 2022-12-31 | LOW |
OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 1.7181 | 1946353 | 441200 | 2022-12-31 | LOW |
Avidity Partners Management LP | Hedge Fund | 1.5879 | 1798900 | 63900 | 2022-12-31 | HIGH |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.5711 | 1779828 | 184128 | 2022-12-31 | LOW |
Braidwell LP | Hedge Fund | 1.4309 | 1621012 | 1621012 | 2022-12-31 | |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.3493 | 1528566 | -53493 | 2022-12-31 | MED |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.3171 | 1492125 | 262940 | 2022-12-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.3059 | 1479376 | 217067 | 2022-12-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Natera, Inc. Company profile
About Natera Inc
Natera, Inc. is a diagnostics company. The Company is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. The Company’s cell-free DNA (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening (HCS), Spectrum Pre-implantation Genetics (Spectrum), Anora Miscarriage Test (Anora), Non-Invasive Paternity Testing (PAT) and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Natera Inc revenues increased 60% to $625.5M. Net loss increased from $229.7M to $471.7M. Revenues reflect Insurance carriers segment increase of 64% to $492.6M, Laboratory and other partners segment increase of 72% to $100M, United States segment increase of 62% to $590.9M, Europe, Middle East, India, Africa segment increase of 43% to $20.4M. Higher net loss reflects Selling.
Industry: | Laboratory Diagnostic & Testing Substances |
13011 Mccallen Pass
Building A Suite 100
AUSTIN
TEXAS 78753
US
Income Statement
- Annual
- Quarterly
News

GBP/EUR forecast: Will the pound rise against the euro in 2023?
The British pound has been moving sideways against the Euro, yet can it regain momentum? Read on for a GBP/EUR forecast.
16:27, 24 March 2023
Shiba Inu price prediction: Can the meme coin build on recent gains?
What’s next for the Shiba Inu meme coin after a sluggish 2022 so far? Read more…
12:51, 24 March 2023
Who are the biggest bitcoin mining companies?
Bitcoin mining is big business, but who are the biggest bitcoin mining companies?
12:06, 24 March 2023
USD/PKR forecast: Will Pakistan’s rupee continue to fall?
The rupee has rebounded against the dollar in recent months, will this trend continue?
11:49, 24 March 2023
Amazon stock forecast: Where next for AMZN amid massive layoffs?
Amazon has been making tens of thousands of its workers redundant. Does this affect the market’s baseline Amazon stock forecast?
10:46, 24 March 2023
Sweatcoin price prediction: What is Sweatcoin?
Can Sweatcoin run to the front of the crypto pack?
15:19, 23 March 2023
Who owns the most bitcoin?
Want to know who owns the most bitcoin? Learn more about the biggest bitcoin whales.
14:54, 23 March 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com